MedTrace Logo

Zestra in Women With Mixed Sexual Dysfunction

NCT00118495 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2007-07-06

No results posted yet for this study

Summary

The objective of this study is to evaluate the clinical efficacy and safety of Zestra(TM) in women with acquired mixed desire/interest/arousal/orgasm disorders under conditions of home usage. The primary efficacy hypothesis will compare the effect of Zestra versus placebo on the incidence of "successful and satisfactory" sexual encounters.

Conditions

  • Sexual Dysfunction, Psychological

Interventions

DRUG

Non-prescription Zestra(TM): patented formulation

Sponsors & Collaborators

  • QualiLife Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • David M Ferguson, PhD, MD, FACCP · Clinical Research Services Consulting

  • Julia R Heiman, PhD · Kinsey Institute for Research in Sex, Gender and Reproduction

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2007-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00118495 on ClinicalTrials.gov